An observational study describing the effectiveness and safety of BLINCYTO® in Chinese adults with Philadelphia chromosome-positive relapsed or refractory B-cell precursor Acute Lymphoblastic Leukemia (Ph+ R/R B-cell precursor ALL) (20210061)

First published 05/01/2024

Last updated 14/07/2025

EU PAS number:

EUPAS107858

Study

Finalised

Documents

Study protocol

Initial protocol

Protocol-Published Original blinatumomab 20210061 .pdf

English (784.85 KB - PDF) View document

Study results

20210061_ORSR_abstract_Redacted (1).pdf

English (1.38 MB - PDF) View document

20210061 ORSR abstract V2.0_Redacted.pdf

English (1.9 MB - PDF) View document

Study report

Other information

Secondary tabs